Find your path to Chris
785 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.
Tyler WilsonunlockedChris: together at Ey (2014–2015)
×11Chris: together at Ey
About
CFO since February 2022 with strong public company and life sciences finance background. Previously served as Corporate Controller at Sucampo Pharmaceuticals (during its $1.2 billion merger with Mallinckrodt) and OpGen. Experienced in capital raises, M&A transactions, and enterprise resource planning in biotech and pharmaceutical sectors.
Experience
- Avalo TherapeuticsChief Financial Officer at Avalo Therapeuticscurrent2022 — present
- Avalo TherapeuticsChief Accounting Officer2021 — 2022
- Avalo TherapeuticsChief Financial Officer - Interim2020 — 2021Rockville, Maryland
- Avalo TherapeuticsVP of Finance other escalating roles2018 — 2020Rockville, Maryland, United States
- Sucampo Pharmaceuticals, Inc.Corporate Controller2017 — 2018Gaithersburg, Maryland
- OpGen, Inc.Corporate Controller2015 — 2017Gaithersburg, MD
- EYSr. Manager2005 — 2015Baltimore, Maryland
Skills & more
SEC Financial Reporting2Financial Analysis3Accounting3
- CPA — AICPA
From Chris's professional profile.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Aaron Kantoff
Managing Partner at Scion Life Sciences
Amy Conrad
Senior Events Manager at Volta Labs
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garrett Lauderdale
Vice President at Idea of La Crosse
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Frequently asked questions
- Who is Chris Sullivan?
- CFO since February 2022 with strong public company and life sciences finance background. Previously served as Corporate Controller at Sucampo Pharmaceuticals (during its $1.2 billion merger with Mallinckrodt) and OpGen. Experienced in capital raises, M&A transactions, and enterprise resource planning in biotech and pharmaceutical sectors.
- Where does Chris Sullivan work?
- Chris Sullivan is Chief Financial Officer at Avalo Therapeutics.
- Where did Chris Sullivan go to school?
- Chris Sullivan studied at University of Maryland (Bachelor's degree of Accounting and Finance, Accounting and Finance).
Same school
Also attended University of Maryland479
Katrina PagliaChief Legal Officer at Pantera CapitalSujal PatelStrategic Director at Madrona Venture GroupDaniel DemmerInvestor at OpenView Venture PartnersDan RochkindCFO at Lerer HippeauAaron EpsteinGeneral Partner at Y CombinatorKevin NiechenInvestment Team at 8VC
+ 473 more
Shared employers
Also worked at Avalo Therapeutics16
Aaron KantoffManaging Partner at Scion Life SciencesSamantha TruexInvestor at Avalo TherapeuticsMittie DoyleChief Medical Officer at Avalo TherapeuticsPaul VarkiChief Legal Officer at Avalo TherapeuticsJennifer RileyChief Strategy Officer at Avalo TherapeuticsTaylor BoydChief Business Officer at Avalo Therapeutics
+ 10 more
Also worked at Sucampo Pharmaceuticals, Inc.2
Also worked at OpGen, Inc.2
Also worked at EY2,000
Tyler WilsonSenior Accountant at Felicis VenturesSandra SchwarzerInvestor at Index VenturesTorjusInvestor at InvestinorAngela ToyPartner & COO at Golden Gate VenturesKirsten MelloPartner + Chief Financial Officer at Menlo VenturesHark AhluwaliaAssociate at Revolution
+ 1,994 more